93 related articles for article (PubMed ID: 8725356)
1. [Functional analysis of transforming growth factor-beta type I receptor].
Saitoh M
Kokubyo Gakkai Zasshi; 1996 Mar; 63(1):42-52. PubMed ID: 8725356
[TBL] [Abstract][Full Text] [Related]
2. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
Saitoh M; Nishitoh H; Amagasa T; Miyazono K; Takagi M; Ichijo H
J Biol Chem; 1996 Feb; 271(5):2769-75. PubMed ID: 8576253
[TBL] [Abstract][Full Text] [Related]
3. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region.
Wieser R; Attisano L; Wrana JL; Massagué J
Mol Cell Biol; 1993 Dec; 13(12):7239-47. PubMed ID: 8246946
[TBL] [Abstract][Full Text] [Related]
4. [Functional analysis of transforming growth factor-beta type II dominant negative receptor].
Takarada M
Kokubyo Gakkai Zasshi; 1996 Jun; 63(2):375-86. PubMed ID: 8741521
[TBL] [Abstract][Full Text] [Related]
5. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.
Wieser R; Wrana JL; Massagué J
EMBO J; 1995 May; 14(10):2199-208. PubMed ID: 7774578
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
Feng XH; Filvaroff EH; Derynck R
J Biol Chem; 1995 Oct; 270(41):24237-45. PubMed ID: 7592630
[TBL] [Abstract][Full Text] [Related]
7. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
Franzén P; Heldin CH; Miyazono K
Biochem Biophys Res Commun; 1995 Feb; 207(2):682-9. PubMed ID: 7864860
[TBL] [Abstract][Full Text] [Related]
8. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex.
Cárcamo J; Zentella A; Massagué J
Mol Cell Biol; 1995 Mar; 15(3):1573-81. PubMed ID: 7862150
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of the intracellular domains of transforming growth factor-beta type I and type II receptors in signal transduction.
Okadome T; Yamashita H; Franzén P; Morén A; Heldin CH; Miyazono K
J Biol Chem; 1994 Dec; 269(49):30753-6. PubMed ID: 7983000
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
[TBL] [Abstract][Full Text] [Related]
11. Complementation between kinase-defective and activation-defective TGF-beta receptors reveals a novel form of receptor cooperativity essential for signaling.
Weis-Garcia F; Massagué J
EMBO J; 1996 Jan; 15(2):276-89. PubMed ID: 8617203
[TBL] [Abstract][Full Text] [Related]
12. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.
Vivien D; Attisano L; Wrana JL; Massagué J
J Biol Chem; 1995 Mar; 270(13):7134-41. PubMed ID: 7706250
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors.
Choi ME; Ballermann BJ
J Biol Chem; 1995 Sep; 270(36):21144-50. PubMed ID: 7673146
[TBL] [Abstract][Full Text] [Related]
14. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene.
Lu SL; Kawabata M; Imamura T; Miyazono K; Yuasa Y
Biochem Biophys Res Commun; 1999 Jun; 259(2):385-90. PubMed ID: 10362519
[TBL] [Abstract][Full Text] [Related]
15. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers.
Stockwell BR; Schreiber SL
Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts.
Zhao Y
Mol Cell Endocrinol; 1999 Apr; 150(1-2):91-7. PubMed ID: 10411303
[TBL] [Abstract][Full Text] [Related]
17. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
Feng XH; Derynck R
EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
[TBL] [Abstract][Full Text] [Related]
18. Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.
Chen T; Yan W; Wells RG; Rimm DL; McNiff J; Leffell D; Reiss M
Int J Cancer; 2001 Sep; 93(5):653-61. PubMed ID: 11477574
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins.
Stockwell BR; Schreiber SL
Chem Biol; 1998 Jul; 5(7):385-95. PubMed ID: 9662508
[TBL] [Abstract][Full Text] [Related]
20. A human transforming growth factor-beta type II receptor that contains an insertion in the extracellular domain.
Hirai R; Fijita T
Exp Cell Res; 1996 Feb; 223(1):135-41. PubMed ID: 8635485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
